Probenecid may elevate the cerebrospinal fluid (CSF) concentration of penicillin G by inhibiting the excretion of organic acids from CSF. We have studied this phenomenon with various penicillin and cephalosporin derivatives. Penicillin concentrations were determined in rabbits under steady-state conditions before and after intravenous probenecid administration. With both low-dose and high-dose probenecid, CSF penicillin levels increased two 10.16 cm) into the threaded female receptacle of the turnbuckle, the animal's head was rigidly but painlessly secured to a modified stereotaxic frame. Next, the posterior alanto-occipital membrane was exposed surgically, and the cisterna magna was carefully punctured using a Quincke spinal needle (3.5 by 25 gauge) mounted in a geared electrode introducer. Clear CSF was withdrawn for cell count. Bloodless CSF was consistently obtained by this method. Animals were maintained under light pentobarbital sedation resulting in no significant changes in arterial blood gases.
Probenecid may elevate the cerebrospinal fluid (CSF) concentration of penicillin G by inhibiting the excretion of organic acids from CSF. We have studied this phenomenon with various penicillin and cephalosporin derivatives. Penicillin concentrations were determined in rabbits under steady-state conditions before and after intravenous probenecid administration. With both low-dose and high-dose probenecid, CSF penicillin levels increased two to three times as did CSF concentration as a percentage of serum level. The same probenecid effect was consistently demonstrated in animals with experimental pneumococcal meningitis. Probenecid likewise increased the CSF concentration of ampicillin, carbenicillin, nafcillin, cephacatrile, and cefazolin. Probenecid may prove useful in certain bacterial infections where high CSF antibiotic levels are necessary.
The low cerebrospinal fluid (CSF) concentrations achieved by penicillin and cephalosporin derivatives may present a problem in the treatment of infections of the nervous system. Probenecid may be effective in raising the CSF concentration of penicillin G (3, 4, 5) . This effect is mediated by inhibition of renal excretion, competitive serum protein binding, and competitive inhibition of carrier-mediated organic acid excretion by choroid plexus (and possibly other peri-CSF systems) (1, 4, 5) .
This study investigates the effect of probenecid on CSF concentrations of various penicillin and cephalosporin derivatives and examines the phenomenon in experimental pneumococcal meningitis. MATERIALS CSF within 1 to 2 h. Thus each animal was used as its own control negating a predictable intra-animal variation.
A total of 480 antibiotic levels were determined by agar well-diffusion techniques. A Bacillus subtilis spore solution (0.125 ml) was added to 100 ml of antibiotic medium no. 1 (Difco) and poured into plates. Wells (0.75 by 0.75 c m) were cut into agar and filled with approximately 0.04 ml of specimens. Zone of inhibition was measured and compared to a standard curve. The standard curve was determined by dissolving known concentrations of antibiotic in pooled rabbit serum and saline (zone sizes for identical concentrations of antibiotic dissolved in rabbit CSF and saline were found to be equal; thus all CSF concentrations were calculated from standard curves with saline diluent).
Production of meningitis. Washed Streptococcus 438 DACEY AND SANDE pneumonie type 3 (10') from a fresh 18-h culture were injected into the CSF via the cisterna magna of five rabbits. The needle was removed. Twelve to 18 h later, animals were lethargic and febrile to 40.5 C. Examination of the CSF revealed purulent meningitis with 4,000 to 6,000 leukocytes, with 95% polymorphonuclear leukocytes and glucose of less than or equal to 40 mg/100 ml. Quantitative cultures before therapy were 10? organisms per ml. Penicillin was administered as described above with probenecid injections beginning 4 h after the start of constant penicillin infusion. Statistical analysis. Data for each animal were processed in the same manner. At least eight samples were assayed before and during probenecid therapy. All values obtained after the steady-state was reached are expressed as a mean standard deviation for each experiment. Differences between groups were determined by Student's t test.
RESULTS
Probenecid was found to increase the CSF concentrations of all penicillin and cephalosporin derivatives tested ( Table 1) .
Effect of probenecid on CSF penicillin concentrations in normal animals. Penicillin did not accumulate in the CSF over the 8-h experimental period. An animal given a constant i.v. penicillin infusion without probenecid was found to have a relatively constant CSF penicillin concentration (mean, 0.3 to 0.4 sg/ml) over the 8-h course (Table 2 ). CSF level expressed as a percentage of serum level was also at 0.4% for 8 h. When low-dose probenecid (10 mg per kg per h) was administered during hours 5 to 8 of penicillin infusion (0.5 million U per kg per h), no change in serum levels occurred but CSF penicillin concentration increased: 0.9 0.2 to 1.7 i 0.3 ,ug/ml (P < 0.01). The CSF concentration expressed as a percentage of serum levels likewise increased, from 0.2 4 0.1% to 0.6 4 0.1% (P< 0.01) (Fig. 1) . When a higher dose of probenecid (20 mg per kg per h) was administered during hours 5 to 8, an increase in serum penicillin levels from 62 + 15 gg/ml to 89 X 15 ,g/ml (P<0.01) occurred, whereas CSF concentrations increased from 0.3 4 0.1 ,ug/ml to 0.9 + 0.3 ug/ml (P< 0.01). This increase was greater than could be explained by the rise in serum concentration, i.e., an increase in CSF level as percentage of serum level from 0.5 i 0.1% to 1.1 4 0.2% (P < 0.01). The CSF concentration of penicillin, expressed as percentage of serum concentration, as well as the response to probenecid were both remarkably consistent over a wide range of serum levels ( Fig. 1 and Table 2 ). Effect of probenecid on CSF penicillin concentrations in experimental meningitis. An (Fig. 2) . This phenomenon was consistent with two other similar experiments: CSF increased from 2.1 ± 0.7 Ag/ml to 14.2 ± 6.4
Ag/ml and from 1.2 ± 0.3 ug/ml to 6.7 i 1.0
,ug/ml (P < 0.01). The CSF concentration expressed as a percentage of serum level also increased, in both experiments, from 3.9 i 1.7% to 6.6 ± 1.8% (P < 0.02) and from 1.7 ± 0.7% to 4.3 ± 0.3% (P < 0.01). Effect of probenecid on penicillin and cephalosporin derivatives. Serum levels of ampicillin rose from 63 + 17 jsg/ml to 115 i 21 tig/ml (P < 0.01) and CSF levels rose from 0.9 + 0.4 jg/ml to 2.5 ± 0.4 uig/ml (P < 0.01) with probenecid administration. As with penicillin, the CSF level expressed as percentage of serum level also increased (1.4 ± 0.3% to 1.9 M 0.1%, P < 0.01) suggesting a direct effect on CSF excretion. Carbenicillin responded to probenecid administration in a similar fashion: serum levels increased from 44 ± 5 ug/ml to 60 ± 8 ,ug/ml (P < 0.01); CSF levels increased from 0.9 ± 0.8 ug/ml to 2.0 i 0.4 ug/ml (P < 0.05); and ANTIMICROB. AG. CHEMOTHER. ,ug/ml to 108 + 199,ug/ml (P < 0.01) and in CSF levels from 0.6 ± 0.4 ug/ml to 1.0 + 0.3 ,ug/ml (P < 0.05) during probenecid administration. Cefazolin responded to probenecid with a similar increase in serum from 143 ± 23 ug/ml to 238 3+ 38,g/ml and in CSF levels from 1.0 i 0.2,g/ml to 1.8 + 0.5 ,ug/ml. Cephacatrile responded to probenecid with an increase in serum concentration from 106 4 10 tsg/ml to 222 + 2 ug/ml (P < 0.01). It is of interest that although animals receiving nafcillin, cefazolin, and cephacatrile had increases in CSF concentrations, the CSF level as a percentage of serum level did not increase significantly (Table 2) . DISCUSSION These data demonstrate that probenecid was effective in elevating the CSF concentration of penicillin in normal rabbits and rabbits in whom experimental S. pneumoniae meninigitis had been produced. This increase was greater than could be explained by the action of probenecid on serum penicillin levels alone, since the CSF level expressed as a percentage of serum level increased in both normal rabbits and rabbits with meningitis. Expression of CSF concentration as a percentage of serum concentration was a concept also used by Fishman to emphasize the effect of probenecid directly on CSF concentrations (5).
Since variation in serum and CSF levels between animals could be expected, experiments were designed so that each animal served as his own control; i.e., the steady-state relationship between CSF and serum levels that developed in hours 1 to 4 (before probenecid administration had begun) was compared with that which developed in each individual animal during hours 5 to 8 (during probenecid administration). In spite of this inter-animal variation, the phenomenon of increasing CSF concentration in excess of increase in serum concentration was consistently present with penicillin. Others have shown in dogs that CSF penicillin levels increase over the course of a 4-h infusion and suggest that the drug accumulates in the CSF compartment (6 The mechanism underlying the effect of probenecid on CSF was investigated primarily by Fishman (5) . In his experiments with three dogs, he determined that probenecid increased the CSF penicillin level and CSF-to-plasma ratio in three ways: it (i) raised blood level, (ii) inhibited active transport of penicillin from CSF, and (iii) competitively bound serum protein with resultant increase in freely diffusable penicillin. Although he demonstrated increased CSF concentrations, brain levels expressed as a percentage of serum concentrations actually decreased with administration of probenecid to rats (5). Dixon et al. (4) reported ventriculocistemal perfusion studies showing selective, active transport of penicillin from ventricular system to blood and its inhibition by paraaminohippurate and diodrast (both organic acids similar to probenecid). The organic acid secretion capacity of the CSF system is localized in choroid plexus epithelium in the lateral, third and fourth ventricles and probably in extrachoroidal sites (1, 2, 4, 5). Dewhurst (3) administered probenecid to 16 patients receiving penicillin and one patient receiving ampicillin for treatment of neurosyphilis and found that probenecid induced a sixfold increase in CSF penicillin concentrations and a threefold increase in CSF ampicillin concentrations. He did not report serum levels.
It is of interest that the action of probenecid on CSF penicillin levels was not diminished but in fact slightly greater in the presence of meningeal inflammation, even with much higher initial CSF penicillin concentrations. This suggests that the organic acid secretion system of CSF is relatively more important in determining CSF penicillin concentration in the presence of meningeal inflammation since more penicillin crosses the blood-CSF barrier and is available for carrier-mediated excretion. An alternative explanation could be that removal of drug by bulk flow might be impeded by the inflammatory response in the subarachnoid space, thereby leaving only the carrier-mediated active transport system for clearance of drug from CSF. Fishman (5) showed that diffusion was an unimportant mechanism for penicillin egress for CSF. Inhibition of this system with probenecid could, therefore, have a more profound effect on increasing CSF concentrations.
The therapeutic implication of this phenomenon may be minimal for penicillin alone since merely by administering larger doses, higher CSF concentrations can be achieved. With other drugs, the achievable CSF levels may only be marginal with standard doses, i.e., Haemophilus influenzae treated with ampicillin, Pseudomonas/Proteus with carbenicillin or ticarcillin. Here the addition of probenecid may have some potential therapeutic usefulness.
